This effect is of clinical relevance in that reduced surface FcγRIIB expression on memory B cells and PCs is often observed in SLE patients, leading to a limited capacity to restrain B cells from activation and to induce apoptosis of PCs (Figure 3) [137]. The gene discussed is FCGR2B; the disease is systemic lupus erythematosus.